Insider Sale by MPM BioVentures 2014, L.P. (10% Owner)
Trade Summary
6 days ago, MPM BioVentures 2014, L.P., serving as 10% owner Owner at Entrada Therapeutics, Inc. (TRDA), sold 259,837 shares at $7.33 per share, for a total transaction value of $1,905,767.81. Following this transaction, MPM BioVentures 2014, L.P. now holds 3,885,115 shares of TRDA.
This sale represents a 6.27% decrease in MPM BioVentures 2014, L.P.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Friday, September 4, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, September 9, 2026 at 7:23 PM ET, 5 days after the trade was made.
Entrada Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.
Trade Price
$7.33
Quantity
259,837
Total Value
$1,905,767.81
Shares Owned
3,885,115
Trade Date
6 days ago
SEC Filing Date
at 7:23 PM ET
Filed 5 days after trade
Discussion